Neonatal encephalopathy (NE) is a clinically diagnosed neurologic disease of neonatal foals that can occur as a result of several antepartum and intrapartum diseases or problems. Clinical signs can range from mild to severe. Treatment of foals with NE is generally supportive, with attention focusing on controlling neurologic dysfunction while supporting metabolic and nutritional needs of the foal.Neonatal encephalopathy (NE) or neonatal maladjustment syndrome (NMS) is a complex disease of neonates and is recognised across different species. The disease is characterised by neurologic dysfunction and can lead to multiorgan dysfunction (Aslam et al., 2019). Other terminologies have been used to describe the disease, including hypoxic ischaemic encephalopathy and perinatal asphyxia; however, these imply a specific pathogenesis relating to hypoxia, ischaemia and asphyxia, which may not be recognised in all cases (Ferriero, 2004;Toribio, 2019;Wong et al., 2011). In this issue, Migliorisi et al. describe a case where a colt displayed signs compatible with NE secondary to perinatal asphyxia (Migliorisi et al., 2023).Reviews, case reports and ongoing investigations demonstrate how our understanding of the disease in foals has evolved and continues to do so (Diesch & Mellor, 2013;Madigan et al., 2012;Mahaffey & Rossdale, 1957;Wong et al., 2011). In newborn babies, the causes of NE include hypoxic ischaemic encephalopathy, perinatal infections, placental abnormalities, metabolic disorders, coagulopathies and neonatal vascular stroke (Aslam et al., 2019). It